Disruption of Kidney-Immune System Crosstalk in Sepsis with Acute Kidney Injury: Lessons Learned from Animal Models and Their Application to Human Health

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2022 Feb 15

PMID 35163625

Authors

Kaice LaFavers

Affiliations

Soon will be listed here.

Abstract

In addition to being a leading cause of morbidity and mortality worldwide, sepsis is also the most common cause of acute kidney injury (AKI). When sepsis leads to the development of AKI, mortality increases dramatically. Since the cardinal feature of sepsis is a dysregulated host response to infection, a disruption of kidney-immune crosstalk is likely to be contributing to worsening prognosis in sepsis with acute kidney injury. Since immune-mediated injury to the kidney could disrupt its protein manufacturing capacity, an investigation of molecules mediating this crosstalk not only helps us understand the sepsis immune response, but also suggests that their supplementation could have a therapeutic effect. Erythropoietin, vitamin D and uromodulin are known to mediate kidney-immune crosstalk and their disrupted production could impact morbidity and mortality in sepsis with acute kidney injury.

Citing Articles

Research hotspots and future trends in sepsis-associated acute kidney injury: a bibliometric and visualization analysis.

Chen X, Zhi L, Chen J, Li R, Long K Front Med (Lausanne). 2025; 11():1456535.

PMID: 39839617 PMC: 11747655. DOI: 10.3389/fmed.2024.1456535.

Vitamin D supplementation may be beneficial in improving the prognosis of patients with sepsis-associated acute kidney injury in the intensive care unit: a retrospective study.

Sun J, Wang Y, Wang J, Wu H, Xu Z, Niu D Front Med (Lausanne). 2024; 11:1453522.

PMID: 39687902 PMC: 11646774. DOI: 10.3389/fmed.2024.1453522.

Evaluation of urinary neutrophil gelatinase associated lipocalin in the early diagnosis of acute kidney injury with sepsis.

Hu L, Zhao Z Am J Transl Res. 2024; 16(4):1266-1272.

PMID: 38715812 PMC: 11070365. DOI: 10.62347/PMAL7041.

Repurposing AZD5438 and Dabrafenib for Cisplatin-Induced AKI.

Pushpan C, Kresock D, Ingersoll M, Lutze R, Keirns D, Hunter W J Am Soc Nephrol. 2023; 35(1):22-40.

PMID: 37962623 PMC: 10786615. DOI: 10.1681/ASN.0000000000000261.

Development of an In Vitro Model for Inflammation Mediated Renal Toxicity Using 3D Renal Tubules and Co-Cultured Human Immune Cells.

Kyun M, Park T, Jung H, Kim I, Kwon J, Jeong S Tissue Eng Regen Med. 2023; 20(7):1173-1190.

PMID: 37843784 PMC: 10645777. DOI: 10.1007/s13770-023-00602-4.

References

Horby P, Lim W, Emberson J, Mafham M, Bell J, Linsell L . Dexamethasone in Hospitalized Patients with Covid-19. N Engl J Med. 2020; 384(8):693-704. PMC: 7383595. DOI: 10.1056/NEJMoa2021436. View

Sica A, Erreni M, Allavena P, Porta C . Macrophage polarization in pathology. Cell Mol Life Sci. 2015; 72(21):4111-26. PMC: 11113543. DOI: 10.1007/s00018-015-1995-y. View

Qu Y, Sun Q, Song X, Jiang Y, Dong H, Zhao W . Helix B surface peptide reduces sepsis-induced kidney injury via PI3K/Akt pathway. Nephrology (Carlton). 2019; 25(7):527-534. DOI: 10.1111/nep.13683. View

Micanovic R, LaFavers K, Garimella P, Wu X, El-Achkar T . Uromodulin (Tamm-Horsfall protein): guardian of urinary and systemic homeostasis. Nephrol Dial Transplant. 2019; 35(1):33-43. PMC: 8205501. DOI: 10.1093/ndt/gfy394. View

Hershman M, Cheadle W, Wellhausen S, Davidson P, Polk Jr H . Monocyte HLA-DR antigen expression characterizes clinical outcome in the trauma patient. Br J Surg. 1990; 77(2):204-7. DOI: 10.1002/bjs.1800770225. View

Hoste E, Lameire N, Vanholder R, Benoit D, Decruyenaere J, Colardyn F . Acute renal failure in patients with sepsis in a surgical ICU: predictive factors, incidence, comorbidity, and outcome. J Am Soc Nephrol. 2003; 14(4):1022-30. DOI: 10.1097/01.asn.0000059863.48590.e9. View

Sursal T, Stearns-Kurosawa D, Itagaki K, Oh S, Sun S, Kurosawa S . Plasma bacterial and mitochondrial DNA distinguish bacterial sepsis from sterile systemic inflammatory response syndrome and quantify inflammatory tissue injury in nonhuman primates. Shock. 2012; 39(1):55-62. PMC: 3537509. DOI: 10.1097/SHK.0b013e318276f4ca. View

Uhlen M, Fagerberg L, Hallstrom B, Lindskog C, Oksvold P, Mardinoglu A . Proteomics. Tissue-based map of the human proteome. Science. 2015; 347(6220):1260419. DOI: 10.1126/science.1260419. View

Munoz C, Carlet J, Fitting C, Misset B, Bleriot J, Cavaillon J . Dysregulation of in vitro cytokine production by monocytes during sepsis. J Clin Invest. 1991; 88(5):1747-54. PMC: 295719. DOI: 10.1172/JCI115493. View

10.

Friedman G, Jankowski S, Marchant A, Goldman M, KAHN R, Vincent J . Blood interleukin 10 levels parallel the severity of septic shock. J Crit Care. 1998; 12(4):183-7. DOI: 10.1016/s0883-9441(97)90030-7. View

11.

Gomez H, Ince C, De Backer D, Pickkers P, Payen D, Hotchkiss J . A unified theory of sepsis-induced acute kidney injury: inflammation, microcirculatory dysfunction, bioenergetics, and the tubular cell adaptation to injury. Shock. 2013; 41(1):3-11. PMC: 3918942. DOI: 10.1097/SHK.0000000000000052. View

12.

Coldewey S, Khan A, Kapoor A, Collino M, Rogazzo M, Brines M . Erythropoietin attenuates acute kidney dysfunction in murine experimental sepsis by activation of the β-common receptor. Kidney Int. 2013; 84(3):482-90. DOI: 10.1038/ki.2013.118. View

13.

Gardlund B, Sjolin J, Nilsson A, Roll M, Wickerts C, Wretlind B . Plasma levels of cytokines in primary septic shock in humans: correlation with disease severity. J Infect Dis. 1995; 172(1):296-301. DOI: 10.1093/infdis/172.1.296. View

14.

Cauwels A . Nitric oxide in shock. Kidney Int. 2007; 72(5):557-65. DOI: 10.1038/sj.ki.5002340. View

15.

Li X, Mu G, Song C, Zhou L, He L, Jin Q . Role of M2 Macrophages in Sepsis-Induced Acute Kidney Injury. Shock. 2017; 50(2):233-239. DOI: 10.1097/SHK.0000000000001006. View

16.

Lerolle N, Nochy D, Guerot E, Bruneval P, Fagon J, Diehl J . Histopathology of septic shock induced acute kidney injury: apoptosis and leukocytic infiltration. Intensive Care Med. 2009; 36(3):471-8. DOI: 10.1007/s00134-009-1723-x. View

17.

Skrifvars M, Moore E, Martensson J, Bailey M, French C, Presneill J . Erythropoietin in traumatic brain injury associated acute kidney injury: A randomized controlled trial. Acta Anaesthesiol Scand. 2018; 63(2):200-207. DOI: 10.1111/aas.13244. View

18.

Zanotti-Cavazzoni S, Goldfarb R . Animal models of sepsis. Crit Care Clin. 2009; 25(4):703-19, vii-viii. DOI: 10.1016/j.ccc.2009.08.005. View

19.

Stoyanoff T, Rodriguez J, Todaro J, Melana Colavita J, Torres A, Aguirre M . Erythropoietin attenuates LPS-induced microvascular damage in a murine model of septic acute kidney injury. Biomed Pharmacother. 2018; 107:1046-1055. DOI: 10.1016/j.biopha.2018.08.087. View

20.

Saemann M, Weichhart T, Zeyda M, Staffler G, Schunn M, Stuhlmeier K . Tamm-Horsfall glycoprotein links innate immune cell activation with adaptive immunity via a Toll-like receptor-4-dependent mechanism. J Clin Invest. 2005; 115(2):468-75. PMC: 544039. DOI: 10.1172/JCI22720. View